Ben Z. Stanger

Gastroenterology

145 King Of Prussia Road
Floor 2, Suite 205 South
Radnor, PA 19087

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 169 publications

Mono-ADP-ribosylation-driven immunosuppression and cross-resistance to therapy through cancer cell intrinsic and extrinsic mechanisms.

Mono-ADP-ribosylation-driven immunosuppression and cross-resistance to therapy through cancer cell intrinsic and extrinsic mechanisms.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.

SPTBN2 promotes an immunosuppressive tumor microenvironment and cross-resistance to anti-cancer therapies.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma.

Journal: Science (New York, N.Y.)

Published: March 12, 2026

Tie2 inhibition disrupts TMEM doorway function and reduces dissemination in pancreatic ductal adenocarcinoma.

Tie2 inhibition disrupts TMEM doorway function and reduces dissemination in pancreatic ductal adenocarcinoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: January 06, 2026

DNA Methylation-Based Classification Uncovers Acinar and Ductal Origins for KPC-Derived PDAC Cell Lines.

DNA Methylation-Based Classification Uncovers Acinar and Ductal Origins for KPC-Derived PDAC Cell Lines.

Journal: Cancer letters

Published: January 02, 2026

DNA methylation-based classification uncovers acinar and ductal origins for KPC-derived PDAC cell lines.

DNA methylation-based classification uncovers acinar and ductal origins for KPC-derived PDAC cell lines.

Journal: Cancer letters

Published: January 02, 2026

TMEM Doorway Mediated Metastasis in Pancreatic Ductal Adenocarcinoma by Tie2 Signaling.

TMEM Doorway Mediated Metastasis in Pancreatic Ductal Adenocarcinoma by Tie2 Signaling.

Journal: bioRxiv : the preprint server for biology

Published: December 22, 2025

Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

Aberrant O-glycosylation Induces IL-34-Mediated Immune Remodeling and Promotes Pancreatic Cancer Progression.

Journal: Cancer research

Published: October 21, 2025

The CA19-9 glycan is a viable target for CAR T cell therapy in pancreatic and other solid tumors.

The CA19-9 glycan is a viable target for CAR T cell therapy in pancreatic and other solid tumors.

Journal: Gastroenterology

Published: October 02, 2025

KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.

KRAS Inhibitors in Pancreas Cancer: Facts and Hopes about the Immunotherapy We Have All Been Waiting for.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 02, 2025

Mitochondrial clone tracing within spatially intact human tissues.

Mitochondrial clone tracing within spatially intact human tissues.

Journal: bioRxiv : the preprint server for biology

Published: August 12, 2025

Plastic hepatocyte states limit liver cancer development.

Plastic hepatocyte states limit liver cancer development.

Journal: Nature communications

Published: July 16, 2025

Showing 1-12 of 169

Last Updated: 09/26/2026